The rise and fall of C-reactive protein: managing demand within clinical biochemistry

H D Hutton1, H S Drummond, A A Fryer

  • 1Department of Clinical Biochemistry, University Hospital of North Staffordshire, Stoke-on-Trent, UK. Hazel.Hutton@uhns.nhs.uk

Insights

Clinical biochemists reduced C-reactive protein (CRP) test requests by 85% in acute admissions units through demand management strategies, saving approximately £10,000 annually. This demonstrates the effectiveness of agreed protocols in controlling laboratory workload.

Area of Science:

  • Clinical Biochemistry
  • Laboratory Medicine
  • Healthcare Management

Background:

  • Laboratory workload management is crucial for clinical biochemists.
  • A significant 31% rise in C-reactive protein (CRP) requests was observed at UHNS.
  • This study aimed to analyze CRP requesting patterns in acute admissions.

Purpose of the Study:

  • To examine C-reactive protein (CRP) requesting patterns within acute admissions units.
  • To assess the impact of demand management strategies on CRP test requests.
  • To identify opportunities for reducing inappropriate test ordering.

Main Methods:

  • Audited current requesting patterns in Accident and Emergency (A&E) and Medical Admissions Units (MAU).
  • Implemented disease-related protocols and consultant-only requesting.
  • Assessed the impact of these demand management strategies on test requests.

Main Results:

  • Initial CRP requests averaged 918/month (A&E) and 545/month (MAU).
  • Demand management strategies achieved an 85% reduction in CRP requests.
  • An IT-based logic rule further reduced duplicate requests within 24 hours, saving ~£10,000 annually.

Conclusions:

  • Demand control strategies at the point of request effectively reduce test numbers from acute units.
  • Agreed protocols in acute settings serve as a valuable demand management tool.
  • This study provides a foundation for addressing inappropriate test requesting.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...